Form 4: HeartBeam Inc. Executive Acquires Stock Options

Kenneth Harry Persen, Chief Technology Officer of HeartBeam, Inc., reports the acquisition of 20,000 stock options.

Summary

• Kenneth Harry Persen, the Chief Technology Officer of HeartBeam, Inc., filed a Form 4 with the SEC.
• The filing reports the acquisition of 20,000 stock options on April 7, 2025, at an exercise price of $1.65.
• The options vest over four years, with 25% vesting immediately and the remainder vesting monthly thereafter.
• These options were issued under the company's 2022 Equity Incentive Plan.
• Following the transaction, Persen directly owns 441,000 shares of Common Stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock option grants, which is neither particularly positive nor negative.

Positives

• The grant of stock options to the CTO aligns his interests with those of the shareholders.
• The vesting schedule incentivizes long-term commitment from the CTO.

Industry Context

Stock option grants are a common practice in the technology industry to incentivize and retain key personnel.

Comparison to Industry Standards

• Stock option grants are a standard component of compensation packages for executives in publicly traded companies, particularly in the tech and biotech sectors.
• Companies like Apple, Google, and Microsoft routinely grant stock options to their executives as part of their overall compensation strategy.
• The vesting schedule of these options, typically over a period of 3-4 years, is also in line with industry norms.

Stakeholder Impact

• The stock option grant aligns the CTO's interests with those of the shareholders, potentially driving long-term value creation.

Key Dates

Keywords

Stock Options, Form 4, HeartBeam, Persen, CTO, Equity